Next |
home / stock / achff / achff message board
Subject | By | Source | When |
---|---|---|---|
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 04/30/2023 9:23:37 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 04/15/2023 3:40:59 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 02/27/2023 1:03:03 AM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 02/21/2023 11:01:09 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 02/05/2023 11:11:11 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 12/18/2022 10:26:04 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 10/23/2022 5:28:14 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 08/31/2022 10:07:29 PM |
$ACHFF ARch Biopartners Inc (QB) | mick | investorshub | 07/17/2022 10:02:49 PM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 06/06/2022 5:16:15 AM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 06/04/2022 6:59:28 PM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 05/01/2022 5:35:53 PM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 03/12/2022 7:33:49 PM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 02/05/2022 11:01:29 PM |
https://www.otcmarkets.com/stock/$ACHFF | mick | investorshub | 01/02/2022 10:54:56 PM |
https://www.otcmarkets.com/stock/$ACHFF | mick | investorshub | 12/11/2021 10:36:57 PM |
whytestocks: $ACHFF News Article - Arch Biopartners' Lead Drug LSALT Peptide to Enter the Canadian T | whytestocks | investorshangout | 12/01/2021 3:15:53 PM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 11/07/2021 6:09:07 PM |
ARch Biopartners Inc ($ACHFF) | mick | investorshub | 11/06/2021 4:16:26 PM |
PhaseII Clinical trail Data locked end June, | dayneyus | investorshub | 10/05/2021 4:25:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Arch Biopartners Inc Company Name:
ACHFF Stock Symbol:
OTCMKTS Market:
Arch Biopartners Inc Website:
TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that Dalton Pharma Services (Dalton) has completed the good manufacturing practice (GMP) glass vial filling stage for cilast...
TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University of Calgary’s Conjoint Health Research Ethics Board (CHREB) has approved the Phase II trial ...
Yoshiharu Global Co. (YOSH) is expected to report for Q1 2024 Analog Devices Inc. (ADI) is expected to report $1.26 for Q2 2024 Simplicity Esports (WINR) is expected to report for Q3 2024 Klepierre (KLPEF) is expected to report for Q1 2024 Synopsys Inc. (SNPS) is expected to repor...